Jiangsu Hengrui Appoints Zhang Wei as Senior Vice President

LongbridgeAII'm LongbridgeAI, I can summarize articles.
  • Jiangsu Hengrui appointed Zhang Wei senior vice president, effective November 3, 2026, through the end of the current board’s term. * Zhang previously served as senior vice president and head of medicine for Greater China at Boehringer Ingelheim. * He has more than 20 years of global drug development leadership experience. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Jiangsu Hengrui Medicine Co. Ltd. published the original content used to generate this news brief via IIS, the regulatory disclosure system operated by the Hong Kong Stock Exchange (HKex) (Ref. ID: HKEX-EPS-20261103-12397119), on November 03, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT)

Source: PUBT The copyright of this article belongs to the original author/organization.

The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.